Evaluation of the clinical and cost effectiveness of intermediate care clinics for diabetes (ICCD): a multicentre cluster randomised controlled trial

A. Wilson, J.P. O’Hare, A. Hardy, N. Raymond, Ala Szczepura, R. Crossman, Darrin Baines, K. Khunti, S. Kumar, P. Saravanan, ICCD trial group

Research output: Contribution to journalArticle

13 Citations (Scopus)
14 Downloads (Pure)

Abstract

Background: Configuring high quality care for the rapidly increasing number of people with type 2 diabetes (T2D) is a major challenge worldwide for both providers and commissioners. In the UK, about two thirds of people with T2D are managed entirely in primary care, with wide variation in management strategies and achievement of targets. Pay for performance, introduced in 2004, initially resulted in improvements but disparities exist in ethnic minorities and the improvements are levelling off. Community based, intermediate care clinics for diabetes (ICCDs) were considered one solution and are functioning across the UK. However, there is no randomised trial evidence for the effectiveness of such clinics. Trial Design, Methods and Findings: This is a cluster-randomised trial, involving 3 primary care trusts, with 49 general practices randomised to usual care (n = 25) or intervention (ICCDs; n = 24). All eligible adult patients with T2D were invited; 1997 were recruited and 1280 followed-up after 18-months intervention. Primary outcome: achievement of all three of the NICE targets [(HbA1c≤7.0%/53 mmol/mol; Blood Pressure
Original languageEnglish
Article numbere93964
JournalPLoS ONE
Volume9
Issue number4
DOIs
Publication statusPublished - 15 Apr 2014
Externally publishedYes

Fingerprint

cost effectiveness
Cost effectiveness
Medical problems
noninsulin-dependent diabetes mellitus
Type 2 Diabetes Mellitus
Cost-Benefit Analysis
diabetes
Randomized Controlled Trials
Primary Health Care
Incentive Reimbursement
Quality of Health Care
General Practice
blood pressure
Blood Pressure
Blood pressure
methodology

Bibliographical note

ClinicalTrials.gov NCT00945204; National Research Register (NRR) M0014178167. : The study is funded by National Institute for Health Research (NIHR) - Health Services and Delivery Research (HS&DR) stream (previously known as NIHR SDO). This is a UK government funding (publicly funded) body. Project number: SDO/110/2005; Initial service for support costs was provided by Department of health.NHS Leicester City, Thames Valley Diabetes Research Network (TVDRN), West Midlands South Comprehensive Local Research Network (CLRN), Primary Care Research Network (PCRN) and DIERT charity provided additional support for the successful completion of the study. Please note Coventry author Dr Baines was working at the University of Warwick at the time of publication.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, http://creativecommons.org/licenses/by/4.0/ which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Keywords

  • diabetes
  • intermediate care clinics
  • cost-effectiveness
  • clinical effectiveness

Cite this

Evaluation of the clinical and cost effectiveness of intermediate care clinics for diabetes (ICCD): a multicentre cluster randomised controlled trial. / Wilson, A.; O’Hare, J.P.; Hardy, A.; Raymond, N.; Szczepura, Ala; Crossman, R.; Baines, Darrin; Khunti, K.; Kumar, S.; Saravanan, P.; ICCD trial group.

In: PLoS ONE, Vol. 9, No. 4, e93964, 15.04.2014.

Research output: Contribution to journalArticle

Wilson, A, O’Hare, JP, Hardy, A, Raymond, N, Szczepura, A, Crossman, R, Baines, D, Khunti, K, Kumar, S, Saravanan, P & ICCD trial group 2014, 'Evaluation of the clinical and cost effectiveness of intermediate care clinics for diabetes (ICCD): a multicentre cluster randomised controlled trial' PLoS ONE, vol. 9, no. 4, e93964. https://doi.org/10.1371/journal.pone.0093964
Wilson, A. ; O’Hare, J.P. ; Hardy, A. ; Raymond, N. ; Szczepura, Ala ; Crossman, R. ; Baines, Darrin ; Khunti, K. ; Kumar, S. ; Saravanan, P. ; ICCD trial group. / Evaluation of the clinical and cost effectiveness of intermediate care clinics for diabetes (ICCD): a multicentre cluster randomised controlled trial. In: PLoS ONE. 2014 ; Vol. 9, No. 4.
@article{46f581a87e434967a1bf722f11e715d0,
title = "Evaluation of the clinical and cost effectiveness of intermediate care clinics for diabetes (ICCD): a multicentre cluster randomised controlled trial",
abstract = "Background: Configuring high quality care for the rapidly increasing number of people with type 2 diabetes (T2D) is a major challenge worldwide for both providers and commissioners. In the UK, about two thirds of people with T2D are managed entirely in primary care, with wide variation in management strategies and achievement of targets. Pay for performance, introduced in 2004, initially resulted in improvements but disparities exist in ethnic minorities and the improvements are levelling off. Community based, intermediate care clinics for diabetes (ICCDs) were considered one solution and are functioning across the UK. However, there is no randomised trial evidence for the effectiveness of such clinics. Trial Design, Methods and Findings: This is a cluster-randomised trial, involving 3 primary care trusts, with 49 general practices randomised to usual care (n = 25) or intervention (ICCDs; n = 24). All eligible adult patients with T2D were invited; 1997 were recruited and 1280 followed-up after 18-months intervention. Primary outcome: achievement of all three of the NICE targets [(HbA1c≤7.0{\%}/53 mmol/mol; Blood Pressure",
keywords = "diabetes, intermediate care clinics, cost-effectiveness, clinical effectiveness",
author = "A. Wilson and J.P. O’Hare and A. Hardy and N. Raymond and Ala Szczepura and R. Crossman and Darrin Baines and K. Khunti and S. Kumar and P. Saravanan and {ICCD trial group}",
note = "ClinicalTrials.gov NCT00945204; National Research Register (NRR) M0014178167. : The study is funded by National Institute for Health Research (NIHR) - Health Services and Delivery Research (HS&DR) stream (previously known as NIHR SDO). This is a UK government funding (publicly funded) body. Project number: SDO/110/2005; Initial service for support costs was provided by Department of health.NHS Leicester City, Thames Valley Diabetes Research Network (TVDRN), West Midlands South Comprehensive Local Research Network (CLRN), Primary Care Research Network (PCRN) and DIERT charity provided additional support for the successful completion of the study. Please note Coventry author Dr Baines was working at the University of Warwick at the time of publication. This is an open-access article distributed under the terms of the Creative Commons Attribution License, http://creativecommons.org/licenses/by/4.0/ which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.",
year = "2014",
month = "4",
day = "15",
doi = "10.1371/journal.pone.0093964",
language = "English",
volume = "9",
journal = "PLoS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "4",

}

TY - JOUR

T1 - Evaluation of the clinical and cost effectiveness of intermediate care clinics for diabetes (ICCD): a multicentre cluster randomised controlled trial

AU - Wilson, A.

AU - O’Hare, J.P.

AU - Hardy, A.

AU - Raymond, N.

AU - Szczepura, Ala

AU - Crossman, R.

AU - Baines, Darrin

AU - Khunti, K.

AU - Kumar, S.

AU - Saravanan, P.

AU - ICCD trial group

N1 - ClinicalTrials.gov NCT00945204; National Research Register (NRR) M0014178167. : The study is funded by National Institute for Health Research (NIHR) - Health Services and Delivery Research (HS&DR) stream (previously known as NIHR SDO). This is a UK government funding (publicly funded) body. Project number: SDO/110/2005; Initial service for support costs was provided by Department of health.NHS Leicester City, Thames Valley Diabetes Research Network (TVDRN), West Midlands South Comprehensive Local Research Network (CLRN), Primary Care Research Network (PCRN) and DIERT charity provided additional support for the successful completion of the study. Please note Coventry author Dr Baines was working at the University of Warwick at the time of publication. This is an open-access article distributed under the terms of the Creative Commons Attribution License, http://creativecommons.org/licenses/by/4.0/ which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PY - 2014/4/15

Y1 - 2014/4/15

N2 - Background: Configuring high quality care for the rapidly increasing number of people with type 2 diabetes (T2D) is a major challenge worldwide for both providers and commissioners. In the UK, about two thirds of people with T2D are managed entirely in primary care, with wide variation in management strategies and achievement of targets. Pay for performance, introduced in 2004, initially resulted in improvements but disparities exist in ethnic minorities and the improvements are levelling off. Community based, intermediate care clinics for diabetes (ICCDs) were considered one solution and are functioning across the UK. However, there is no randomised trial evidence for the effectiveness of such clinics. Trial Design, Methods and Findings: This is a cluster-randomised trial, involving 3 primary care trusts, with 49 general practices randomised to usual care (n = 25) or intervention (ICCDs; n = 24). All eligible adult patients with T2D were invited; 1997 were recruited and 1280 followed-up after 18-months intervention. Primary outcome: achievement of all three of the NICE targets [(HbA1c≤7.0%/53 mmol/mol; Blood Pressure

AB - Background: Configuring high quality care for the rapidly increasing number of people with type 2 diabetes (T2D) is a major challenge worldwide for both providers and commissioners. In the UK, about two thirds of people with T2D are managed entirely in primary care, with wide variation in management strategies and achievement of targets. Pay for performance, introduced in 2004, initially resulted in improvements but disparities exist in ethnic minorities and the improvements are levelling off. Community based, intermediate care clinics for diabetes (ICCDs) were considered one solution and are functioning across the UK. However, there is no randomised trial evidence for the effectiveness of such clinics. Trial Design, Methods and Findings: This is a cluster-randomised trial, involving 3 primary care trusts, with 49 general practices randomised to usual care (n = 25) or intervention (ICCDs; n = 24). All eligible adult patients with T2D were invited; 1997 were recruited and 1280 followed-up after 18-months intervention. Primary outcome: achievement of all three of the NICE targets [(HbA1c≤7.0%/53 mmol/mol; Blood Pressure

KW - diabetes

KW - intermediate care clinics

KW - cost-effectiveness

KW - clinical effectiveness

U2 - 10.1371/journal.pone.0093964

DO - 10.1371/journal.pone.0093964

M3 - Article

VL - 9

JO - PLoS ONE

JF - PLoS ONE

SN - 1932-6203

IS - 4

M1 - e93964

ER -